Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against 3D Systems Corporation for alleged violations of federal securities laws, urging affected investors to contact them before the August 12, 2025 deadline for lead plaintiff applications in a federal class action lawsuit [2][4]. Financial Performance - 3D Systems reported Q4 2024 non-GAAP earnings-per-share of -$0.19, missing consensus estimates by $0.08, with sales revenue of $111 million, a year-over-year decline of 3.4%, and a full-year 2024 sales total of $440.1 million, down 10% from the previous year [5]. - In Q1 2025, the company reported revenue of $94.5 million, an 8% year-over-year decline, and a net loss of $37 million, or $0.28 per share, which is more than double the $16 million loss reported in Q1 2024 [6]. Stock Price Reaction - Following the Q4 2024 results announcement, 3D Systems' stock price fell by $0.57, or 20.96%, closing at $2.15 per share [5]. - After the Q1 2025 results were released, the stock price dropped by $0.68, or 26.6%, to close at $1.87 per share [7]. Allegations of Misconduct - The complaint against 3D Systems alleges that the company and its executives made false or misleading statements regarding the impact of weakened customer spending and overstated the company's resilience in challenging market conditions [4]. - It is also claimed that updated milestone criteria in the United Partnership would negatively affect the revenue from the Regenerative Medicine Program, leading to materially false public statements [4].

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD). Shareholders who purchased shares of DDD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/3d-systems-corporation-loss-submission-form/?id=155073&from=3 CLASS PERIOD: Aug ...

Core Viewpoint - Investors in 3D Systems Corporation have the opportunity to lead a securities fraud class action lawsuit due to alleged misrepresentations by the company regarding its financial health and business operations [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit claims that from August 13, 2024, to May 12, 2025, 3D Systems failed to disclose significant information, including the understatement of weakened customer spending's impact on the business and the overstatement of the company's resilience in tough industry conditions [2]. - It is alleged that updated milestone criteria in the United Partnership would adversely affect the revenue from the Regenerative Medicine Program [2]. - The positive statements made by the defendants regarding the company's business, operations, and prospects were claimed to be materially misleading and lacked a reasonable basis during the relevant period [2]. Participation Information - Investors who suffered losses are encouraged to participate in the ongoing lawsuit before the lead plaintiff deadline of August 12, 2025 [2]. - Interested parties can contact the Law Offices of Frank R. Cruz for more information or to participate in the class action [3][4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against 3D Systems Corporation due to alleged violations of federal securities laws, encouraging affected investors to come forward before the August 12, 2025 deadline for lead plaintiff applications in a federal securities class action [3][5]. Financial Performance - 3D Systems reported Q4 2024 non-GAAP earnings-per-share of -$0.19, missing consensus estimates by $0.08, with sales revenue of $111 million, reflecting a year-over-year decline of 3.4% and missing estimates by $4.17 million [6]. - For the full year 2024, the company reported sales of $440.1 million, a decrease of 10% compared to the previous year, attributed to lower hardware systems sales due to macroeconomic factors [6]. - In Q1 2025, 3D Systems reported revenue of $94.5 million, down 8% year-over-year, and a net loss of $37 million, or $0.28 per share, more than doubling the loss from Q1 2024 [8]. Stock Price Reaction - Following the Q4 2024 results announcement, 3D Systems' stock price fell by $0.57, or 20.96%, closing at $2.15 per share [7]. - After the Q1 2025 results were released, the stock price dropped by $0.68, or 26.6%, closing at $1.87 per share [9]. Allegations and Legal Context - The complaint against 3D Systems alleges that the company and its executives made false and misleading statements regarding customer spending and the impact on the company's business, as well as the revenue from its Regenerative Medicine Program [5]. - The firm is encouraging anyone with information regarding 3D Systems' conduct to come forward, including whistleblowers and former employees [11].

Core Viewpoint - 3D Systems Corporation is facing a class action lawsuit due to significant financial losses and misleading statements made by the company regarding its business performance and outlook during the Class Period from August 13, 2024, to May 12, 2025 [1][5]. Financial Performance - On March 26, 2025, 3D Systems reported its Q4 and full-year 2024 results, missing consensus estimates for non-GAAP earnings-per-share and sales revenue, attributing the shortfall to lower hardware systems sales caused by macroeconomic factors [2]. - The company experienced a revenue reduction of $9 million in Q4 due to changes in accounting estimates related to its Regenerative Medicine program [2]. - Following this announcement, the stock price dropped by $0.57, or 21%, closing at $2.15 per share on March 27, 2025 [2]. - On May 12, 2025, 3D Systems released its Q1 2025 results, again missing estimates, primarily due to a decline in material sales linked to inventory management issues in its Healthcare Solutions segment [3]. - The company withdrew its full-year 2025 outlook, citing ongoing softness in customer capital spending and macroeconomic uncertainty [3]. - The stock price fell further by $0.68, or 26.6%, closing at $1.87 per share on May 13, 2025 [4]. Lawsuit Details - The class action lawsuit alleges that 3D Systems made materially false and misleading statements and failed to disclose adverse facts about its business and prospects during the Class Period [5]. - Specific allegations include the understatement of the impact of weakened customer spending and the overstatement of the company's resilience in challenging conditions [5]. - The lawsuit claims that the updated milestone criteria in the United Partnership negatively affected the revenue from the Regenerative Medicine Program [5].

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of 3D Systems Corporation investors who were adversely affected by alleged securities fraud between August 13, 2024 and May 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In 3D Systems To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in 3D System between August 13, 2024 and May 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 28, 2025 (GLOBE ...

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- , June 27, 2025 – Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of 3D Systems Corporation investors who were adversely affected by alleged securities fraud between August 13, 2024 and May 12, 2025. Follow the link below to get more information and be contacted by a member of our team: htt ...

Group 1 - The article initiates coverage on 3D Systems Corporation (NYSE: DDD) with a Strong Buy rating and a price target of $4, highlighting its end-to-end additive manufacturing and digital manufacturing capabilities across various sectors including healthcare, dental, aerospace, and biotech [1] - Moretus Research focuses on identifying companies with durable business models, mispriced cash flow potential, and intelligent capital allocation, applying a structured framework to deliver high-quality equity research [1] - The valuation approach used by Moretus Research emphasizes pragmatic, sector-relevant multiples tailored to each company's business model and capital structure, aiming for comparability, simplicity, and relevance [1] Group 2 - Research coverage by Moretus tends to favor underappreciated companies undergoing structural change or temporary dislocation, where disciplined analysis can lead to asymmetric returns [1] - Moretus Research aims to raise the standard for independent investment research by providing professional-grade insights, actionable valuation, and a strong filter for what truly matters in modern equity analysis [1]

Core Viewpoint - A class action lawsuit has been filed against 3D Systems Corporation, alleging that the company made misleading statements regarding its financial health and the impact of customer spending on its business [3][4]. Group 1: Class Action Details - The class action represents investors who purchased securities between August 13, 2024, and May 12, 2025, with a deadline of August 12, 2025, to file a lead plaintiff motion [1]. - The Portnoy Law Firm is offering complimentary case evaluations to investors seeking to recover losses [2]. Group 2: Allegations Against 3D Systems - The lawsuit claims that 3D Systems understated the impact of weakened customer spending and overstated its resilience to market challenges [3]. - It is alleged that changes in the partnership with United Therapeutics Corporation would negatively affect revenue from the Regenerative Medicine Program [3]. Group 3: Financial Performance - On March 26, 2025, 3D Systems reported a Q4 non-GAAP loss of $0.19 per share, missing consensus estimates by $0.08, with Q4 revenue of $111 million, down 3.4% year-over-year [6]. - The full-year revenue for 2024 was reported at $440.1 million, reflecting a 10% decline year-over-year due to lower hardware sales and macroeconomic challenges [6]. - Following the Q1 2025 results announcement on May 12, 2025, the stock fell more than 26%, with a reported net loss of $37 million, more than double the loss from Q1 2024 [4][6].